Algernon Pharmaceuticals Inc.

2023-0303 – Stock Split - Algernon Pharmaceuticals Inc. (AGN)

le 1 mars/March 2023

Algernon Pharmaceuticals Inc. has announced a four (4) for one (1) stock split of its issued and outstanding common shares. Each shareholder of record as of the close of business on the record date will receive three (3) additional shares for each share held on such date.

2021-0122 - Expiry – Algernon Pharmaceuticals Inc. – Warrants (AGN.WT)

le 19 janvier/January 2021

Further to Bulletin 2020-1240, Algernon Pharmaceuticals Inc. warrants will expire on January 21, 2021.

Settlement Terms:  All trades January 19^th and 20^th  will settle for cash next day. Trades on January 21 will be for cash same day.

The warrants will be halted at noon and delisted at market close January 21, 2021.

2018-1021 – Consolidation - Breathtec BioMedical Inc. (BTH)

Le 16 octobre/October 2018

Breathtec BioMedical Inc. has announced a consolidation of its issued and outstanding share capital on the basis of one (1) post-consolidation share for each two (2) pre-consolidation common shares. 

As a result, the outstanding shares of the company will be reduced to approximately 28,682,012.

The shares will begin trading on a consolidated basis and with a new CUSIP number on October 17, 2018.

The name and symbol will not change.